A combination strategy targeting enhancer plasticity exerts synergistic lethality against BETi-resistant leukemia cells
Epigenetic changes can drive drug resistance in cancer. Here, the authors show that in BET inhibitor resistant leukaemia cells, genome-wide enhancer remodelling drives therapeutic resistance and targeting enhancer plasticity may overcome this resistance.
Saved in:
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/cd93c24dbe33431eb092362dd139a9cb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|